![](https://investorshub.advfn.com/uicon/438654.png?cb=1584701726)
Wednesday, April 08, 2020 6:39:51 PM
That is good confirmation..
https://alphastocknews.com/tonix-pharmaceuticals-tnxp-stock-gains-on-covid-19-sec-filing/2885/
Let’s be honest, presenting to WHO is very different from presenting at an investing conference. Should the World Health Organization find sources of validity with regard to the potential of Tonix Pharmaceuticals’ vaccine to be effective against COVID-19, the vaccine may be recommended.
Should this vaccine be recommended by the WHO, we will likely see a domino effect, whereby the FDA moves quickly to approve the vaccine and several larger company’s approach TNXP for licensing and partnership discussions.
This filing is nothing small, and if the data being presented is as meaningful as I and the rest of the investing community believe will be, the opportunity here could be incredible for TNXP and all involved.
Those who look for HOME RUN in pennyland eventually BECOME HOMELESS
Be Careful out there
Recent TNXP News
- Tonix Pharmaceuticals Announces Potential Positive Impact of the U.S. National Academies (NASEM) New Definition of Long COVID on the Size of the Fibromyalgia Market for Tonmya™ • GlobeNewswire Inc. • 07/31/2024 12:00:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/30/2024 09:17:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/30/2024 09:08:39 PM
- Tonix Pharmaceuticals Announces Poster Presentation at the IASP 2024 World Congress on Pain • GlobeNewswire Inc. • 07/30/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/25/2024 12:06:45 PM
- Tonix Pharmaceuticals Granted Fast Track Designation by FDA for Tonmya™ for Fibromyalgia • GlobeNewswire Inc. • 07/25/2024 12:00:00 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 07/24/2024 09:14:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/16/2024 01:12:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/10/2024 08:48:25 PM
- Tonix Pharmaceuticals Announces Closing of $4.0 Million Public Offering • GlobeNewswire Inc. • 07/10/2024 08:30:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/09/2024 08:33:32 PM
- Tonix Pharmaceuticals Announces Pricing of Approximately $4.0 Million Public Offering • GlobeNewswire Inc. • 07/09/2024 01:15:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/08/2024 09:01:36 PM
- Tonix Pharmaceuticals Announces Proposed Public Offering • GlobeNewswire Inc. • 07/08/2024 09:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/08/2024 12:05:24 PM
- Tonix Pharmaceuticals Reports Final Positive Pre-NDA Meeting with FDA for Tonmya™ for the Management of Fibromyalgia • GlobeNewswire Inc. • 07/08/2024 12:00:00 PM
- Tonix Pharmaceuticals Awarded Up to $34 Million U.S. Department of Defense Contract for Accelerated Development of Broad-Spectrum Antiviral Program • GlobeNewswire Inc. • 07/01/2024 12:00:00 PM
- Tonix Pharmaceuticals Announces Closing of $4.0 Million Public Offering • GlobeNewswire Inc. • 06/28/2024 08:05:00 PM
- Tonix Pharmaceuticals Announces Pricing of Approximately $4.0 Million Public Offering • GlobeNewswire Inc. • 06/27/2024 12:36:51 PM
- Tonix Pharmaceuticals Announces Proposed Public Offering • GlobeNewswire Inc. • 06/26/2024 08:40:16 PM
- Tonix Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement • GlobeNewswire Inc. • 06/26/2024 07:13:29 PM
- Tonix Pharmaceuticals Presents Vaccine Platform Data in Keynote Talk at the Vaccine Congress 2024 • GlobeNewswire Inc. • 06/25/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/20/2024 12:05:23 PM
- Tonix Pharmaceuticals Announces Positive Pre-NDA CMC Meeting with FDA for Tonmya™ for the Management of Fibromyalgia • GlobeNewswire Inc. • 06/20/2024 12:00:00 PM
- Tonix Pharmaceuticals Presented Data Comparing Real-World Treatment of Migraine with Industry Guidelines for Non-Oral Products at the Annual Scientific Meeting of the American Headache Society (AHS) • GlobeNewswire Inc. • 06/18/2024 12:00:00 PM
Kona Gold Beverages, Inc. Announces Strategic Initiatives and Corporate Direction Changes • KGKG • Aug 2, 2024 2:00 PM
POET and Luxshare Tech Expand Product Offerings for Artificial Intelligence Networks • POET • Aug 1, 2024 9:28 AM
Management Discusses Financial Filings of Global Arena Holding Inc., for 10-K 2023 and 10-Q, 1st Quarter 2024 • GAHC • Aug 1, 2024 9:14 AM
VAYK Announces LOI to Acquire $1 Million Home Service Company to Support Airbnb Business • VAYK • Aug 1, 2024 9:00 AM
Duane Forrester Joins INDEXR as SVP of Search • MONI • Jul 31, 2024 11:46 AM
Lingerie Fighting Championships Help Fulfill Death-Bed Promise With First Major Motion Picture • BOTY • Jul 31, 2024 9:00 AM